# A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service

> **NCT06261567** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 415 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Biologic treatment

## Key facts

- **NCT ID:** NCT06261567
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-27
- **Primary completion:** 2024-08-20
- **Final completion:** 2024-08-20
- **Target enrollment:** 415 (ACTUAL)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06261567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06261567, "A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06261567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*